FIELD: pharmacology.
SUBSTANCE: invention relates to an analgesic means in which individual substituted quinoline-4(1H)-ones of general formula 1 their salts or compositions based on them are active substances, and which can be used as an anesthetic to treat humans and animals, where R1 = phenyl unsubstituted or substituted by one substituent selected from alkyl (C1-C4), alkoxy (OC1-OC4), halogen; phenyl substituted by two substituents selected from methyl, ethyl, methoxy, ethoxy or halogen; unsubstituted naphthyl, unsubstituted thienyl or thienyl substituted by one substituent selected from methyl or halogen; unsubstituted furyl, C4-alkyl, OMe; R2+R3 = =O, =NOMe, R4=H, COOMe, COOH; R5= H, Me; R6th= H, Me, OMe, Et, halogen; R7th= H, halogen, CN; R8= H, alkyl (C1-C4), halogen, CN.
EFFECT: expansion arsenal of anesthetic means.
2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ANALGESIC AGENT | 2018 |
|
RU2711968C1 |
SEDATIVE BASED ON 4-QUINOLONES | 2021 |
|
RU2780622C1 |
QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
USE OF SIGMA LIGANDS WITH INDUCED OPIOIDS HYPERALGESIA | 2011 |
|
RU2589899C2 |
AMINOCYCLOBUTANE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS DRUGS | 2013 |
|
RU2655919C2 |
RADICAL BINDING AGENT BASED ON ACYLPYRUVIC ACID DERIVATIVES | 2022 |
|
RU2800386C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2697090C1 |
SIGMA LIGANDS FOR POTENTIATING ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POSTOPERATIVE PAIN AND ATTENUATING DEPENDENCY THEREOF | 2011 |
|
RU2563460C2 |
CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION | 2014 |
|
RU2665709C2 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
Authors
Dates
2017-11-02—Published
2016-05-04—Filed